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topoisomerase I, and genetic defects
increasing these transcriptional DSBs
cause neurological disorders.
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Although accumulation of DNA damage and genomic
instability in resting cells can cause neurodegenera-
tive disorders, our understanding of how transcrip-
tion produces DNA double-strand breaks (DSBs)
is limited. Transcription-blocking topoisomerase I
cleavage complexes (TOP1ccs) are frequent events
that prime DSB production in non-replicating cells.
Here, we report a mechanism of their formation by
showing that they arise from two nearby single-
strand breaks (SSBs) on opposing DNA strands:
one SSB from the removal of transcription-blocking
TOP1ccs by the TDP1 pathway and the other from
the cleavage of R-loops by endonucleases, including
XPF, XPG, and FEN1. Genetic defects in TOP1cc
removal (TDP1, PNKP, and XRCC1) or in the resolu-
tion of R-loops (SETX) enhance DSB formation and
prevent their repair. Such deficiencies cause neuro-
logical disorders. Owing to the high frequency of
TOP1cc trapping and the widespread distribution
of R-loops, these persistent transcriptional DSBs
could accumulate over time in neuronal cells,
contributing to the neurodegenerative diseases.
INTRODUCTION
In metazoans, most cells are slow- or non-replicating, and the
accumulation of DNA damage and genomic instability in such
cells can cause several human diseases, including neurodegen-
erative syndromes (McKinnon, 2017; Rass et al., 2007). Even so,
exactly how DNA double-strand breaks (DSBs), the most harm-
ful genomic lesions, are generated in resting cells is unclear.
Increasing evidence indicates that transcription can induce
DNA damage and genomic instability, particularly throughCell Repo
This is an open access article under the CC BY-NR-loop structures (Aguilera and Garcı´a-Muse, 2012; Aguilera
and Go´mez-Gonza´lez, 2017; Sollier and Cimprich, 2015).
Furthermore, co-transcriptional R-loops have been associated
with neurodegenerative diseases (Groh and Gromak, 2014).
R-loops consist of a RNA/DNA hybrid and a displaced single-
strand DNA, formed by the reannealing of the nascent transcript
with the transcribed DNA strand behind the elongating RNA po-
lymerase II (Pol II). R-loops are widespread dynamic structures
(Sanz et al., 2016). They occur naturally during transcription
and have important physiological functions, such as gene
expression, DNA replication, and repair (Santos-Pereira and
Aguilera, 2015; Skourti-Stathaki and Proudfoot, 2014; Sollier
and Cimprich, 2015). Several factors regulate R-loop homeosta-
sis and so prevent the accumulation of unscheduled R-loops and
DNA damage, including topoisomerase I (TOP1) (Drolet et al.,
2003; El Hage et al., 2010; Manzo et al., 2018) and mRNA pro-
cessing factors (Huertas and Aguilera, 2003; Li and Manley,
2005). Once formed, R-loops can be removed by RNase H
enzymes, which degrade the RNA in the RNA/DNA hybrids (Cer-
ritelli and Crouch, 2009), and by RNA/DNA helicases, such as
senataxin (SETX) (Groh et al., 2017; Skourti-Stathaki et al.,
2011), aquarius (AQR) (Sollier et al., 2014), and DHX9 (Cristini
et al., 2018), which unwind the RNA/DNA hybrids.
Deregulation of TOP1 activity is a source of transcription-
associated genomic instability, also associated with neurode-
generative disorders (Jiang et al., 2017; Katyal et al., 2014;
Pommier et al., 2016; Takashima et al., 2002). TOP1 solves
DNA topological problems arising during transcription. It relaxes
both positive and negative DNA supercoiling generated ahead
and behind the elongating Pol II, respectively, by forming tran-
sient TOP1 cleavage complexes (TOP1ccs), which are TOP1-
linked single-strand breaks (SSBs) (Pommier et al., 2016). After
DNA relaxation, TOP1ccs reverse rapidly and TOP1 is released.
These transient TOP1ccs are readily stabilized or ‘‘trapped’’ on
chromatin under physiological or pathological conditions, giving
rise to irreversible TOP1ccs. DNA alterations, including oxidative
lesions, base mismatches, modifications and losses, and DNArts 28, 3167–3181, September 17, 2019 ª 2019 The Authors. 3167
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
breaks, can trap TOP1ccs (Huang et al., 2017; Pommier et al.,
2016). Genetic defects in TDP1, ATM, and XRCC1 proteins
cause neurological disorders and result in long-lived TOP1ccs
(Hoch et al., 2017; Jiang et al., 2017; Katyal et al., 2014; Pommier
et al., 2016; Takashima et al., 2002). TOP1ccs are selectively
trapped by camptothecin (CPT) and its derivatives used as anti-
cancer agents (Pommier, 2006).
Trapped TOP1ccs are potent transcription-blocking DNA le-
sions (Capranico et al., 2007; Pommier, 2006), and their repair
depends primarily on the TDP1 excision pathway (Cristini
et al., 2016; El-Khamisy et al., 2005; Miao et al., 2006; Yang
et al., 1996). Although TOP1 depletion increases R-loop levels
(Drolet et al., 2003; El Hage et al., 2010; Manzo et al., 2018; Tu-
duri et al., 2009), the effect of TOP1cc trapping on R-loops is less
well understood except for specific genes, including snord116
(Powell et al., 2013), frataxin in Friedreich ataxia cells (Groh
et al., 2014), and b-actin (Cristini et al., 2018), where R-loops
are increased in response to CPT and/or derivatives. A conse-
quence of transcription blocking by TOP1ccs is the production
of DSBs, which have been detected in non-replicating cells,
such as post-mitotic neurons (Sordet et al., 2009) and quiescent
fibroblasts (Cristini et al., 2016). Here, we describe how these
DSBs are produced and so provide a molecular mechanism
that strictly depends on transcription. We show that these
DSBs can arise from two nearby SSBs on opposing DNA
strands, both produced during transcription: one SSB results
from removal of a transcription-blocking TOP1cc by the TDP1
pathway and the other from cleavage of an R-loop by struc-
ture-specific endonucleases. Notably, genetic defects in the
transcription-blocking TOP1cc removal pathway or in the resolu-
tion of R-loops enhance DSB levels by increasing their produc-
tion and preventing their repair and lead to cell death. Such
defects may underlie neurological diseases. Given the frequency
of TOP1ccs and the widespread distribution of R-loops, these
persistent transcriptional DSBs will accumulate over time in
neuronal cells and so contribute to neurodegenerative diseases.
RESULTS
Transcriptional DSBs Depend on SSB Intermediates
Produced during TOP1cc Removal
To investigate how DSBs are produced in response to transcrip-
tion-blocking TOP1ccs, we induced these breaks by exposing
quiescent WI38 hTERT fibroblasts to CPT (Cristini et al., 2016).
CPT induces high levels of stabilized TOP1ccs (Pommier,
2006). Quiescence was controlled by the lack of 5-ethynyl-20-de-
oxyuridine (EdU) incorporation into DNA (Figures S1A and S1B)
as reported (Cristini et al., 2016). These transcriptional DSBs
can be visualized by microscopy as nuclear foci containing
gH2AX (phosphorylated H2AX at S139) and p53BP1 (phosphor-
ylated 53BP1 at S1778; Figures 1A and 1B) and by neutral comet
assays as increased comet tail moment (Figures 1C and 1D).
We previously showed that TOP1 degradation by the ubiqui-
tin-proteasome pathway is required for the production of tran-
scriptional DSBs in CPT-treated quiescent cells (Cristini et al.,
2016). TOP1 degradation primes the repair of transcription-
blocking TOP1ccs, giving rise to a DNA single-strand break
(SSB) intermediate, which is successively processed by TDP13168 Cell Reports 28, 3167–3181, September 17, 2019and PNKP at the 30 end before DNA re-ligation by the DNA ligase
3-XRCC1 complex (Figure 1E). Here, we asked whether these
SSB intermediates contribute to the formation of transcriptional
DSBs.
We also reported that TDP1-depleted cells, which accumulate
TOP1 peptide-linked SSB intermediates (Figure 1E; El-Khamisy
et al., 2005; Interthal et al., 2005; Miao et al., 2006), accumulate
transcriptional DSBs in response to CPT (Cristini et al., 2016). To
further examine the role of SSB intermediates, we depleted
PNKP and the DNA ligase 3-XRCC1 complex to accumulate
cellular SSBs with 30-P and 30-OH, respectively (Figure 1E;
Ashour et al., 2015; Pommier et al., 2014). RNAi-mediated
knockdown of PNKP and DNA ligase 3 in quiescent cells
increased the number of gH2AX and p53BP1 foci in response
to CPT (Figures 1F–1I, S1C, and S1D), which correlated with
increased SSBs in alkaline comet assays (Figures S1F and
S1G). Inhibition of TOP1 degradation with the proteasome inhib-
itor MG132, which prevented the generation of these SSB inter-
mediates (Ashour et al., 2015; Pommier et al., 2014), suppressed
the induction of gH2AX foci by CPT upon depletion of PNKP and
DNA ligase 3 (Figures 1G and 1I). Under these conditions,
p53BP1 foci could not be assessed because MG132 prevents
the ubiquitin-dependent accumulation of 53BP1 at DSB sites
(Mailand et al., 2007). The transcriptional origin of these DSB-
associated foci was established by the use of flavopiridol, an
inhibitor of Pol II transcription (Figures 1G, 1I, S1C, and S1D).
Likewise, depletion of XRCC1, which also decreased the levels
of DNA ligase 3 (Figure 1J; Caldecott et al., 1995), induced a
MG132- and flavopiridol-sensitive increase of gH2AX and/or
p53BP1 foci in response to CPT (Figures 1K and S1E). Together,
these results indicate that the SSB intermediates produced dur-
ing the removal of transcription-blocking TOP1ccs give rise to
DSBs in non-replicating cells.
The Formation of Transcriptional DSBs Depends on
R-Loops
A possible mechanism for the formation of DSBs in non-repli-
cating cells is that the SSB intermediate produced during the
removal of a transcription-blocking TOP1cc would be converted
into a DSB by a nearby SSB on the opposing DNA strand.
Notably, R-loop structures that form co-transcriptionally in an
unscheduled manner are prone to DNA breakage (Aguilera and
Go´mez-Gonza´lez, 2017; Sollier and Cimprich, 2015). We there-
fore determined whether R-loops could be linked to the produc-
tion of a SSB on the opposing DNA strand.
Although TOP1 depletion is known to increase R-loop levels
(Drolet et al., 2003; El Hage et al., 2010; Manzo et al., 2018; Tu-
duri et al., 2009), the effect of TOP1cc trapping on R-loops is still
unclear. To address this, quiescent cells were exposed to CPT
and R-loop levels were assessed by a DNA slot blot assay em-
ploying S9.6 antibody (Boguslawski et al., 1986). CPT did not
significantly affect S9.6 signal, albeit a small and transient in-
crease was observed after 5 min, consistent with previous re-
ports (Figures 2A and 2B; Marinello et al., 2013, 2016). RNase
H treatment suppressed S9.6 signal, indicating its specificity
for RNA/DNA hybrids (Figures 2A and 2B). These results indi-
cate that TOP1cc trapping does not significantly increase
R-loop levels. We therefore hypothesized that TOP1cc trapping
Figure 1. Depletion of PNKP, DNA Ligase 3, or XRCC1 Increases CPT-Induced Transcription- and Proteasome-Dependent DSBs in
Quiescent Cells
(A and B) Quiescent cells were treated with CPT (25 mM; 1 h) and co-stained for gH2AX (green) and p53BP1 (red).
(A) Representative confocal microscopy pictures. Yellow indicates colocalization. Dashed lines indicate nuclei. Scale bars: 10 mm.
(B) Number of gH2AX and p53BP1 foci per nucleus. ****p < 0.0001 (one-way ANOVA).
(C and D) Detection of DSBs by neutral comet assays in quiescent cells treated with CPT (25 mM; 1 h).
(C) Representative pictures of nuclei.
(D) Quantification of neutral comet tail moments. ****p < 0.0001 (two-tailed unpaired t test).
(E) Pathway for the removal of a transcription-blocking TOP1cc. Y: TOP1 catalytic tyrosine.
(F–K) Quiescent cells were transfected with the indicated siRNAs.
(F, H, and J) Western blot probed with PNKP (F), Ligase 3 (H), and XRCC1 and Ligase 3 (J). a-tubulin, KAP1: loading controls.
(G, I, and K) Cells transfected with siRNAs against PNKP (G), Ligase 3 (I), and XRCC1 (K) were treated with MG132 (25 mM) or flavopiridol (1 mM) for 1 h before the
addition of CPT (25 mM; 1 h) and co-stained for gH2AX and p53BP1. The number of gH2AX foci per nucleus is shown. ****p < 0.0001 (one-way ANOVA).
(B, D, G, I, and K) A representative experiment out ofR3 is shown.
See also Figure S1.could instead cause a genomic redistribution of R-loops. In sup-
port to this possibility, CPT readily inhibited transcription (Fig-
ures 2C and 2D; Cristini et al., 2016; Desai et al., 2003) and
therefore could decrease the levels of physiological R-loops
that have a rapid turnover (10–20 min) and are enriched 1 to
2 kb downstream of transcription start site (TSS) of expressedgenes (Sanz et al., 2016). Conversely, CPT could increase
R-loops in the body of genes where it primarily traps TOP1ccs
and blocks transcription (Baranello et al., 2016; Solier et al.,
2013; Sordet et al., 2008).
Therefore, we examined R-loops at the TSS-proximal and
gene body regions using RNA/DNA hybrid immunoprecipitationCell Reports 28, 3167–3181, September 17, 2019 3169
(legend on next page)
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(DRIP) with the S9.6 antibody. Consistent with the prevalent
localization of physiological R-loops at promoter-proximal re-
gions (Sanz et al., 2016; Skourti-Stathaki et al., 2011), RNase
H-sensitive DRIP signals were detected at TSS-proximal regions
of b-actin and g-actin genes in untreated quiescent cells (Fig-
ure 2E, white bars). CPT induced a rapid drop of DRIP signals
at TSS-proximal regions together with an increase in the body
of these genes (Figure 2E). Such increase of DRIP signals was
also observed over PTB and Gemin7 genes (Figure 2E). These
results indicate that TOP1cc trapping by CPT treatment in-
creases R-loop levels over gene bodies.
To assess the role of R-loops in TOP1cc-dependent tran-
scriptional DSBs, we investigated whether R-loops form at
DSB sites. Chromatin immunoprecipitation (ChIP) analysis
showed an enrichment of gH2AX after CPT exposure on
b-actin, g-actin, PTB, and Gemin7 genes (Figure 2F), coin-
ciding with positions of R-loop enrichment (Figure 2E). To
assess the direct consequences of R-loops, we tested
whether modulating their cellular levels could impact DSB for-
mation. First, we decreased R-loops by overexpressing RNase
H1. We took advantage of U2OS cells inducible for mCherry or
mCherry-RNase H1 fusion protein (Figure 2G; Britton et al.,
2014). These cells cannot enter quiescence; hence, we
analyzed DSBs in G1, prior to DNA replication. CPT-induced
DSBs in G1 cells were also dependent on transcription and
TOP1 degradation (Figure S2A), indicating that these DSBs
are produced by a mechanism similar to quiescent cells (Fig-
ures 1 and S1). RNase H1 overexpression decreased the
number of gH2AX foci induced by CPT in G1 cells (Figure 2H).
Second, we increased R-loops by depleting SETX or AQR
(Groh et al., 2017; Skourti-Stathaki et al., 2011; Sollier et al.,
2014). Small interfering RNA (siRNA)-mediated knockdown of
SETX or AQR increased the number of gH2AX and p53BP1
foci in CPT-treated quiescent cells (Figures 2I, 2J, and S2B–
S2D). SETX depletion also increased DRIP signals over
b-actin, PTB, and Gemin7 genes (Figure S2E). Together, these
data indicate that R-loops contribute to the formation of
TOP1cc-induced transcriptional DSBs in non-replicating cells.Figure 2. CPT Induces R-Loop-Dependent DSBs in the Absence of DN
(A and B) RNA/DNA hybrid slot blot of genomic DNA ± RNase H from quiescent
(A) Representative slot blot. ssDNA: loading control.
(B) Values are normalized to ssDNA (means ± SEM; nR 2). not significant (ns; tw
(C andD) Immunofluorescence (IF) analysis of 5-ethynyl uridine (EU) incorporation
the last 30 min of CPT treatment.
(C) Representative pictures. EU (green); propidium iodide (PI; red); scale bars: 10
(D) Values are normalized to untreated cells (means ± SEM; n = 3). ****p < 0.000
(E) DRIP analysis in quiescent cells treated with 25 mMCPT. Values are normalized
cells (means ± SEM; n = 3). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (tw
(F) gH2AX and H2AX ChIP analysis in quiescent cells treated with CPT (25 mM; 1 h
(IL-4): negative control.
(G and H) U2OS cells were treated with doxycycline to express mCherry or mCh
(G) Western blot of mCherry. Actin: loading control.
(H) Cells were incubated with 10 mM EdU for 30 min before treatment with CPT
gH2AX foci per G1 nucleus (EdU-negative and low Hoechst 33342) is shown.
(I and J) Quiescent cells were transfected with siCtrl or siSETX.
(I) Western blot of SETX. *non-specific band. a-tubulin: loading control.
(J) siRNA-transfected cells were treated with CPT (25 mM; 1 h) and co-stained fo
A representative experiment out of 2 (H) or 3 (J) is shown. ****p < 0.0001 (two-ta
See also Figure S2.Structure-Specific Endonucleases Cleave R-Loops to
Produce Transcriptional DSBs
Next, we asked whether the SSBs in R-loops could contribute to
DSB production. Because R-loops form single-stranded DNA
structures with flap extremities, we tested whether the inhibition
of structure-specific endonucleases that can cleave related
structures can prevent the induction of DSBs in CPT-treated
quiescent cells. XPF, XPG, FEN1, MRE11, ARTEMIS, CtIP, and
MUS81 all possess flap endonuclease activity (Dehe´ and Gail-
lard, 2017; Regairaz et al., 2011). RNAi-mediated depletion of
XPF, XPG, FEN1, or MRE11, but not of ARTEMIS, CtIP, or
MUS81, reduced the induction of gH2AX and p53BP1 foci by
CPT (Figures 3 and S3). These results support a role for R-loop
cleavage in the production of TOP1cc-mediated transcriptional
DSBs and further suggest that these breaks can be mediated
by several endonucleases, including XPF, XPG, FEN1, and
MRE11. To further examine the mechanism of endonuclease-
mediated R-loop cleavage in the production of these DSBs, we
initially focused on XPF because its depletion had the most se-
vere defect in DSB induction (Figures 3 and S3).
We first asked whether XPF is recruited to R-loops in
response to CPT. ChIP analysis in quiescent cells showed an
enrichment of XPF after CPT treatment over b-actin, g-actin,
PTB, and Gemin7 genes (Figure 4A), coinciding with R-loop
accumulation (Figure 2E). To test whether XPF binds to
R-loops, we used the R-loop immunoprecipitation (IP) method
we recently developed, which allows the identification of
RNA/DNA hybrid-interacting proteins in cells (Figure 4B; Cristini
et al., 2018). XPF was enriched in RNA/DNA hybrid IP samples
compared to the nuclear lamin B protein and ‘‘no antibody’’ IP
samples in untreated quiescent cells (Figure 4C), indicating that
XPF binds to R-loops under physiological conditions. Cellular
exposure to CPT resulted in a further enrichment of XPF in
the RNA/DNA hybrid IP (Figures 4C and 4D), and the quantity
of RNA/DNA hybrid IPs was comparable (Figure S4A). The
interaction of XPF with RNA/DNA hybrids is specific as it was
reduced by RNase H treatment and prevented by synthetic
RNA/DNA hybrid competitors added into IP reaction (FiguresA Replication
cells treated with 25 mM CPT.
o-tailed unpaired t test).
in quiescent cells treatedwith CPT (25 mM; 1 h) and incubated with 1mMEU for
mm.
1 (two-tailed unpaired t test).
to b-actin ‘‘TSS proximal’’ amplicon of the ‘‘RNase H’’ sample from untreated
o-tailed unpaired t test). Intergenic: negative control.
). Values are normalized to untreated cells (means ± SEM; nR 2). Interleukin-4
erry-RNase H1.
(25 mM; 1 h) and stained for gH2AX and Hoechst 33342 (DNA). The number of
r gH2AX and p53BP1. The number of gH2AX foci per nucleus is shown.
iled unpaired t test).
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Figure 3. Depletion of the Nucleases XPF, XPG, FEN1, and MRE11 Reduces the Induction of DSBs in CPT-Treated Quiescent Cells
Quiescent cells were transfected with the indicated siRNAs.
(A) Western blot probed with the indicated antibodies. Actin, a-tubulin, and KAP1: loading controls.
(B–H) Cells transfected with siRNAs against XPF (B), XPG (C), FEN1 (D), MRE11 (E), ARTEMIS (F), CtIP (G), andMUS81 (H) were treated with CPT (25 mM; 1 h) and
co-stained for gH2AX and p53BP1. The number of gH2AX foci per nucleus is shown. A representative experiment out ofR3 is shown. The data with siCtrl cells in
(D) and (G) are from the same experiment. ns, *p < 0.05, **p <0.01, ****p < 0.0001 (two-tailed unpaired t test).
(I) The fold induction of gH2AX was calculated by subtracting the number of foci of untreated cells from that of CPT-treated cells and normalized to siCtrl cells
treated with CPT (means ± SEM; nR 3). ns, *p < 0.05, **p < 0.01, ***p < 0.001 (two-tailed unpaired t test).
See also Figure S3.S4B–S4D). These results indicate that XPF is enriched on gene
body R-loops in response to CPT in non-replicating cells.
To determine whether XPF cleaves R-loops to produce
DSBs, we tested whether the endonuclease activity of XPF
is required for this process. We analyzed gH2AX induction
by CPT in the G1 population of XPF-deficient cells (XP-F) com-
plemented with either a wild-type (XPF-WT) or a nuclease-
dead (XPF-D676A) XPF (Staresincic et al., 2009). CPT
increased the number of gH2AX foci in XPF-WT cells
compared to XPF-deficient cells, and this increase was lost
in XPF-nuclease-dead cells (Figure 4E). Thus, the nuclease ac-
tivity of XPF is required for the production of TOP1cc-depen-
dent transcriptional DSBs. To further test whether XPF cleaves
R-loops, we analyzed the effects of XPF depletion on R-loop-
dependent DNA breaks. By using alkaline comet assays to3172 Cell Reports 28, 3167–3181, September 17, 2019detect SSBs, we showed that increasing R-loop levels upon
RNAi-mediated depletion of SETX resulted in an increase of
SSBs in CPT-treated quiescent cells (Figure 4F). Such in-
crease was suppressed by XPF depletion (Figure 4F), suggest-
ing that XPF induces SSBs within R-loops. To evaluate the
contribution of XPF-mediated R-loop cleavage to the forma-
tion of DSBs, we carried out the same experiments but
analyzed DSBs instead of SSBs. XPF depletion also sup-
pressed the increase of gH2AX foci induced by CPT upon
SETX depletion (Figure 4G). Similar results were obtained by
increasing R-loops upon AQR depletion (Figure S4E).
Conversely, decreasing R-loops by RNase H1 overexpression
did not further decrease the induction of gH2AX by CPT upon
XPF depletion in the G1 population of U2OS cells (Figure S4F).
Taken together, these results indicate that XPF can cleave
Figure 4. R-Loop-Dependent DSBs Are Mediated by XPF, XPG, and FEN1 in Non-replicating Cells Treated with CPT
(A) ChIP analysis of XPF in quiescent cells treated with CPT (25 mM; 20 min). Values are normalized to untreated cells (means ± SEM; n = 4). ns, *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001 (two-tailed unpaired t test). Intergenic: negative control.
(B) R-loop IP method for the detection of R-loop-associated proteins.
(C and D) R-loop IP was carried out in quiescent cells treated with CPT (25 mM; 20 min). Input and IP fractions were probed with XPF or lamin B1 antibodies.
(legend continued on next page)
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R-loops formed upon TOP1cc trapping and that such cleavage
can generate DSBs independently of replication.
To assess whether XPG and FEN1 act on the same R-loops as
XPF to induce DSB formation, we depleted these endonucleases
in combination in quiescent cells. Co-depletion of XPF with XPG
or FEN1 did not further decrease the number of gH2AX foci
induced by CPT than the depletion of XPF alone (Figures 4H,
left and middle panels, 4I, and S4G), suggesting that XPF and
XPG, as well as XPF and FEN1, act on the same R-loops. The
FEN1 nuclease inhibitor myricetin (Ma et al., 2019) decreased
the induction of gH2AX and p53BP1 foci by CPT (Figures S4H
and S4I), further supporting the role of FEN1 in the cleavage of
R-loops. Because XPF possesses a 30-flap endonuclease activ-
ity and XPG and FEN1 a 50-flap endonuclease activity (Dehe´ and
Gaillard, 2017), these results suggest that R-loops are cleaved at
both 30- and 50-extremities to induce DSB formation in CPT-
treated quiescent cells. Then, the two 50-flap endonucleases,
XPG and FEN1, were depleted together to assess whether
they act on the same R-loops. Co-depletion of XPG and FEN1
showed an additive effect in decreasing the number of gH2AX
foci induced by CPT (Figures 4H, right panel, and 4I), suggesting
that XPG and FEN1 act on different R-loops. Notably, co-deple-
tion of XPG and FEN1 decreased the number of gH2AX to the
same extent as the depletion of XPF alone (Figure 4I), further
suggesting that XPG and FEN1 are the main 50-flap endonucle-
ases that act with the 30-flap endonuclease XPF on the R-loops.
Taken together, these results suggest that R-loops are cleaved
at both extremities by a dual incision mediated by XPG and
XPF or FEN1 and XPF to induce the formation of co-transcrip-
tional DSB in CPT-treated quiescent cells.
The Formation of Transcriptional DSBs Requires the
Dual Processing of TOP1ccs and R-Loops
Our data are consistent with the possibility that, in non-repli-
cating cells, the SSB intermediates produced during the removal
of transcription-blocking TOP1ccs are converted into DSBs by
the presence of nearby SSBs on opposing DNA strand gener-
ated by the cleavage of R-loops. However, another possibility
is that the endonucleases cleave R-loops on both strands,
generating DSBs independently of TOP1cc-dependent SSB
intermediates.
To distinguish between these two possibilities, we tested
whether R-loop-dependent DSBs were also dependent on
SSBs generated during TOP1cc removal. We therefore induced
R-loop-dependent DSBs by depleting SETX in CPT-treated(C) Representative immunoblots.
(D) Quantification of R-loop IP. Values were normalized to input and DMSO sam
(E) XPF-deficient patient cell line (XP-F) complemented with a wild-type (XPF-W
30min before treatment with CPT (25 mM; 1 h) and stained for gH2AX andHoechst
Hoechst 33342) is shown. ns, ****p < 0.0001 (two-tailed unpaired t test).
(F–I) Quiescent cells were transfected with the indicated siRNAs and treated with
(F) Detection of SSBs by alkaline comet assays. The quantification of comet tail
(G) Number of gH2AX foci per nucleus. ****p < 0.0001 (one-way ANOVA).
(H) Number of gH2AX foci per nucleus. ns, *p < 0.05, ****p < 0.0001 (one-way AN
(I) The fold induction of gH2AX was calculated by subtracting the number of foci
treated with CPT in each experiment (means ± SEM; nR 3). ns, *p < 0.05, **p <
A representative experiment out of 2 (E and G) orR3 (F and H) is shown.
See also Figure S4.
3174 Cell Reports 28, 3167–3181, September 17, 2019quiescent cells while inhibiting TOP1 proteolysis with protea-
some inhibitors to prevent the formation of TOP1cc-induced
SSB intermediates (Figure 1E; Ashour et al., 2015; Pommier
et al., 2014). Proteasome inhibitors MG132 and bortezomib sup-
pressed the induction of gH2AX foci by CPT upon SETX deple-
tion (Figure 5A). Although SETX can be recruited at DSBs (Cohen
et al., 2018), ChIP analysis showed that MG132 did not prevent
SETX recruitment at the b-actin, g-actin, and PTB genes (Fig-
ure S5), indicating that SETX recruitment to these loci is not
due to DSBs but rather due to the presence of R-loops. Consis-
tent with that, MG132 also did not reduce R-loop levels
measured byDNA slot blot (Figures 5B and 5C) and byDRIP (Fig-
ure 5D), excluding the possibility that fewer R-loops account for
the lack of DSB induction. In addition, alkaline comet assays
showed that MG132 did not prevent the induction of SSBs within
the R-loops (Figure 5E). These results indicate that, in non-repli-
cating cells, the cleavage of R-loops alone is insufficient to
generate DSBs and that it requires the formation of SSB interme-
diates produced during the removal of TOP1ccs. Altogether,
these results support a model where, in non-replicating cells, a
transcription-blocking TOP1cc is converted into a DSB by the
presence of two SSBs on opposing DNA strand: one SSB result-
ing from TOP1cc removal and the other from cleavage of an
R-loop by endonucleases.
Removal of TOP1ccs and R-Loops Allows the Repair of
Transcriptional DSBs
Based on this model, TDP1-deficient cells should have DSBs
with 30-DNA broken strands attached to TOP1 peptides (i.e.,
TOP1 partially proteolyzed; see Figure 1E), which is likely to pre-
vent DSB repair. Indeed, the DNA endmust be cleansed to allow
DSB repair by non-homologous end joining (NHEJ) (Kawale
et al., 2018; Menon and Povirk, 2016), which is the main repair
pathway in G0/G1 cells (Hendrickson, 1997). Similarly, cells
with deficiencies in R-loop resolution factors, such as SETX,
will have persistent RNA/DNA hybrids between the two SSBs,
which would need to be resolved to allow DSB repair. Our next
question was therefore whether cells deficient for one of these
pathways, in addition to forming higher levels of transcriptional
DSBs, would also be unable to repair them. We therefore
analyzed the effects of TDP1 and SETX depletion on the repair
of CPT-induced transcriptional DSBs.
To determine the kinetics of DSB repair, we analyzed
the reversal kinetics of DSB-associated foci (Lo¨brich et al.,
2010). Cells were exposed to CPT, washed free of drug, andple (means ± SEM; n = 3). *p < 0.05 (two-tailed unpaired t test).
T) or a nuclease-dead (XPF-D676A) XPF were incubated with 10 mM EdU for
33342 (DNA). The number of gH2AX foci per G1 nucleus (EdU-negative and low
CPT (25 mM; 1 h).
moments is shown. ****p < 0.0001 (one-way ANOVA).
OVA).
of untreated cells from that of CPT-treated cells and normalized to siCtrl cells
0.01, ****p < 0.0001 (two-tailed unpaired t test).
Figure 5. Proteasome Inhibition Prevents R-Loop-Dependent DSBs in CPT-Treated Quiescent Cells
(A) Quiescent cells were transfected with siCtrl or siSETX, treated with MG132 (25 mM; 1 h) or bortezomib (1 mM; 4 h) before the addition of CPT (25 mM; 1 h), and
stained for gH2AX. The number of gH2AX foci per nucleus is shown.
(B and C) RNA/DNA hybrid slot blot of genomic DNA from quiescent cells treated with MG132 (10 mM; 1 h) before the addition of CPT (25 mM; 1 h), probed with
S9.6 and ssDNA antibodies.
(B) Representative slot blot. ssDNA: loading control.
(C) Quantification of RNA/DNA hybrid slot blot. Values are normalized to ssDNA (means ± SEM; n = 4).
(D) DRIP analysis from quiescent cells treated as in (B) and (C). Values are normalized to b-actin TSS proximal from untreated cells (means ±SEM; n = 3). *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001 (two-tailed unpaired t test).
(E) Detection of SSBs by alkaline comet assays in cells transfected and treated as in (A). The quantification of comet tail moments is shown.
A representative experiment out of 2 is shown in (A) and (E); ns, *p < 0.05, ****p < 0.0001 (one-way ANOVA).
See also Figure S5.gH2AX/p53BP1 foci were monitored post-CPT treatment (Fig-
ure 6A) as reported (Mamouni et al., 2014). In quiescent cells,
the number of gH2AX and p53BP1 foci decreased rapidly after
CPT removal. However, reversal kinetic was faster for p53BP1
foci than for gH2AX foci (Figures S6A and S6B). Neutral comet
assays showed a reversal of about 80%, 1 h after CPT removal
(Figures S6C and S6D), which correlates with p53BP1 reversal
kinetics. Therefore, we chose p53BP1 to study DSB repair.
RNAi-mediated depletion of TDP1 led to persistent p53BP1
foci after CPT removal in quiescent cells (Figures 6B–6D). Sucha defect in p53BP1 reversal kinetics was also observed in the
G1 population of HCT116 cells knockout (KO) for TDP1 (Figures
6E and 6F). Similarly, RNAi-mediated depletion of SETX led to
persistent p53BP1 foci after CPT removal in quiescent cells (Fig-
ures 6G and 6H). These results indicate that cells deficient for
TOP1cc removal or R-loop resolution form high levels of tran-
scriptional DSBs due to their defective repair.
Besides NHEJ, DSBs can be repaired in G0/G1 cells by the
single-strand annealing (SSA) pathway. SSA consists of the an-
nealing of homologous repeat sequences and requires theCell Reports 28, 3167–3181, September 17, 2019 3175
Figure 6. TDP1- and SETX-Deficient Cells
Are Defective for the Repair of CPT-Induced
Non-replicating DSBs
(A) Protocol to study p53BP1 foci reversal
following CPT removal used in (C), (D), and (F)–(H).
Cells were treated with CPT (25 mM; 1 h), washed
(W), and cultured in CPT-free medium for up to 6 h
(release).
(B–D) Quiescent cells were transfected with siCtrl
or siTDP1.
(B) Western blot of TDP1. a-tubulin: loading
control.
(C) Number of p53BP1 foci per nucleus.
(D) The percentages of p53BP1 foci remaining
following CPT removal were calculated by sub-
tracting the number of foci of untreated cells
from that of treated cells and normalized to cells
treated with CPT (means ± SEM; n = 4). *p < 0.05,
**p < 0.01, ***p < 0.001 (two-tailed unpaired t test).
(E) Western blot of TDP1 in TDP1WT and TDP1 KO
HCT116 cells.
(F) p53BP1 foci in G1 nuclei (EdU-negative and low
Hoechst 33342) of TDP1 WT and TDP1 KO
HCT116 cells.
(G) Similar experiment as in (C) in quiescent cells
transfected with siSETX.
(H) Similar experiment as in (D) in quiescent cells
transfected with siSETX. Means ± SEM; n = 3. ns,
*p < 0.05, **p < 0.01 (two-tailed unpaired t test).
A representative experiment out ofR2 is shown in
(C), (F), and (G).
See also Figure S6.RAD52 protein (Ceccaldi et al., 2016). RNAi-mediated depletion
of RAD52 in quiescent cells did not affect the reversal kinetics of
p53BP1 foci upon CPT removal (Figures S6E and S6F). These re-
sults suggest that, in quiescent cells, transcriptional DSBs are
not repaired by the SSA pathway, thus supporting repair by
NHEJ.
TOP1cc- and R-Loop-Dependent Transcriptional DSBs
Accumulate under Physiological Conditions
CPT selectively traps TOP1ccs (Nitiss and Wang, 1988; Pom-
mier, 2006), and hence, it is a precise tool to dissect the produc-
tion mechanism of TOP1cc-dependent transcriptional DSBs.
Besides CPT, awide range of DNA alterations can trap TOP1ccs,
and many of them are frequent (Pommier et al., 2016). To deter-
mine whether transcriptional DSBs could form under physiolog-
ical conditions by a mechanism that relies on TOP1ccs and
R-loop processing, we analyzed DSBs in quiescent cells under
normal cultured conditions without CPT.
RNAi-mediated depletion of TDP1 (Figure 6B) increased the
number of gH2AX and p53BP1 foci (Figures 7A, S7A, and
S7C), indicating that SSB intermediates produced during
TOP1cc removal promote DSB formation. Concurrent depletion
of XPF suppressed the induction of gH2AX and p53BP1 foci
upon TDP1 knockdown (Figures 7A, S7A, and S7C), suggesting
that DSBs formed upon depletion of TDP1 depend on SSBs
within the R-loops. To control that XPF cleaves R-loops to3176 Cell Reports 28, 3167–3181, September 17, 2019form DSBs, we increased R-loop levels and prevented their
cleavage by depletion of SETX and XPF, respectively. The in-
crease of gH2AX and p53BP1 foci upon depletion of SETX was
abrogated by the concurrent depletion of XPF (Figures 7B,
S7B, and S7C). Together, these results led us to conclude that
TOP1cc-dependent transcriptional DSBs form under physiolog-
ical conditions and involve the dual processing of TOP1cc and
R-loops.
To assess whether these transcriptional DSBs affect the
viability of non-replicative cells, we tested the effect of CPT-
dependent DSB formation on the survival of quiescent cells.
Increasing DSBs by depleting PNKP with siRNA (Figures 1F
and 1G) decreased cell survival in response to CPT (Figure 7C),
whereas decreasing DSBs by depleting XPF with siRNA (Figures
3A and 3B) increased cell survival (Figure 7C). These results
highlight the physiological relevance of transcription-dependent
DSBs induced by the dual processing of TOP1ccs and R-loops
in non-replicating cells.
DISCUSSION
Genomic instability in resting cells is an emerging cause of
neurodegenerative syndromes. Even so, our understanding of
how DSBs are produced in non-replicating cells is limited.
Here, we report a mechanism of DSB formation that strictly de-
pends on transcription. DSBs are generated by two nearby SSBs
Figure 7. Depletion of XPF Prevents the Induction of DSBs upon Depletion of TDP1 in Quiescent Cells
(A and B) Quiescent cells were transfected with the indicated siRNAs and co-stained for gH2AX and p53BP1. To compare XPF-proficient (siCtrl) and XPF-
deficient (siXPF) cells upon depletion of TDP1 (A) or SETX (B), gH2AX induction was normalized to 1 in both siCtrl and siXPF cells (means ± SEM; n = 3). **p < 0.01,
***p < 0.001 (two-tailed unpaired t test).
(C) Viability of siRNA-transfected quiescent cells treated with 25 mM CPT (means ± SEM of triplicates).
(D) Model for the induction of DSBs during transcription. (a) TOP1 removes both positive and negative DNA supercoiling (Sc) generated during transcription. (b)
Stabilization of a TOP1cc on the template strand blocks Pol II transcription and promotes R-loop formation. (c) The transcription-blocking TOP1cc is partially
proteolyzed by the ubiquitin-proteasome system, which reveals the SSB. The R-loop is cleaved by a dual incision mediated by XPG and XPF or FEN1 and XPF
(legend continued on next page)
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on opposing DNA strands, both produced during transcription.
One SSB arises from the repair of a transcription-blocking
TOP1cc by the TDP1 pathway and the other from cleavage of
an R-loop by endonucleases. Our data can be explained by
the model in Figure 7D, where the SSB resulting from TOP1cc
removal is on the transcribed DNA strand ahead of Pol II and
the SSB in the R-loop is behind Pol II on the non-transcribed
DNA strand displaced by the RNA/DNA hybrid. This polarity is
in agreement with previous work showing that a TOP1cc located
specifically on the transcribed strand blocks transcription (Bend-
ixen et al., 1990; Wu and Liu, 1997) and is converted into an
irreversible TOP1cc (Wu and Liu, 1997), the removal of which
depends primarily on the TDP1 pathway (Cristini et al., 2016;
El-Khamisy et al., 2005; Miao et al., 2006; Yang et al., 1996). In
addition, R-loops form behind the elongating Pol II (Huertas
and Aguilera, 2003), and the single-stranded nature of the dis-
placed DNA strand within the R-loop makes it more vulnerable
to DNA damage (Sollier and Cimprich, 2015).
An alternative model could be that the SSB generated during
TOP1cc removal is located on the RNA/DNA hybrid within the
R-loop or a few base pairs away from it. This is plausible as
TOP1 removes negative DNA supercoiling behind the elongating
Pol II (Pommier et al., 2016) and TOP1 co-immunoprecipitates
with RNA/DNA hybrids (Cristini et al., 2018). However, it has
not been reported that CPT can trap TOP1ccs in RNA/DNA hy-
brids and, if so, whether this would lead to irreversible TOP1ccs,
the removal of which would depend on TDP1. Nevertheless, our
results showing that the production of SSBs at R-loops is sup-
pressed by XPF depletion (Figure 4F) argue against the possibil-
ity that TOP1ccs generate SSBs in RNA/DNA hybrids in our cell
model.
Our data support that CPT increases R-loops in gene bodies,
which is consistent with previous work showing that this is where
TOP1ccs are primarily trapped (Baranello et al., 2016; Solier
et al., 2013). Persistent TOP1ccs represent a barrier to the elon-
gating Pol II (Bendixen et al., 1990; Sordet et al., 2008; Wu and
Liu, 1997), which could promote R-loop formation by displacing
spliceosomes (Tresini et al., 2015). Also, TOP1ccs could favor
R-loop formation by increasing non-coding RNAs, such as anti-
sense RNAs (Graf et al., 2017; Marinello et al., 2013, 2016; No-
jima et al., 2018). A recent genome-wide analysis following
TOP1 depletion shows R-loop gains in gene bodies (Manzo
et al., 2018), suggesting that the decrease in TOP1 activity could
also account for the effects of CPT on R-loops. Such a decrease
in TOP1 activity could promote R-loop formation as a result of
negative supercoiling accumulating behind the elongating Pol II
(Drolet et al., 2003) and/or inhibition of the serine and arginine-
rich (SR)-kinase activity of TOP1 interfering with splicing (Li
and Manley, 2005; Tuduri et al., 2009).
Unscheduled R-loops can induce DSBs and genomic insta-
bility (Aguilera and Garcı´a-Muse, 2012; Sollier and Cimprich,
2015). Our analysis in non-replicating cells suggests that agenerating a SSB on the opposing DNA strand. Stalled Pol II is degraded and/or r
Boxes indicate human disorders associated with increase of TOP1cc (blue) o
amyotrophic lateral sclerosis; AOA, ataxia with oculomotor apraxia; AT, ataxia tela
muscular atrophy; SMN, survival motor neuron.
See also Figure S7.
3178 Cell Reports 28, 3167–3181, September 17, 2019DSB does not form directly in the R-loop by the cleavage of
both strands. Instead, a SSB is produced on the displaced
DNA strand within the R-loop and the DSB is created by a sec-
ond SSB next to the R-loop on the opposing DNA strand. In repli-
cating cells, it is also plausible that a SSBwithin the R-loop could
be converted into a DSB as the DNA replicates. Our data show
that the SSB in the R-loop is mediated by the nucleases XPF,
XPG, and FEN1. Consistently, XPF and XPG have been reported
to cleave R-loops in vitro (Tian and Alt, 2000) and in cells (Sollier
et al., 2014; Yasuhara et al., 2018), and FEN1 contributes to
R-loop resolution during telomere replication (Teasley et al.,
2015). XPF has a 30-flap endonuclease activity, whereas XPG
and FEN1 have a 50-flap activity (Dehe´ and Gaillard, 2017). Our
results from nuclease co-depletion experiments support amodel
in which R-loops are cleaved at both 30- and 50-extremities to
induce DSBs by a dual incision mediated by XPF and XPG or
XPF and FEN1. Although the cleavage at both ends of the
R-loops might occur independently of each other, it is possible
that it is more coordinated, e.g., that the cleavage at one end
primes the cleavage at the other end. AlthoughMRE11 is primar-
ily involved in DSB repair by homologous recombination (Cec-
caldi et al., 2016), it is unlikely that it contributes to the repair
of transcriptional DSBs in quiescent cells due to the absence
of sister chromatids for recombination. MRE11 has both an
endonuclease and an exonuclease activity. It may therefore pro-
mote DSB formation by cleaving R-loops and/or by resecting
DNA after a break is produced. Nuclease-independent functions
of MRE11 may also contribute, including recruitment and activa-
tion of ATM (Buis et al., 2008), ultimately resulting in TOP1 degra-
dation (Katyal et al., 2014) and further induction of transcriptional
DSBs (this study; Cristini et al., 2016).
Although the twoSSBsonopposingDNAstrandscanbedistant
fromeachother, it is plausible that theygive rise to aDSBbecause
the DNA strands in between, i.e., in the R-loop and the transcrip-
tionbubble, arenotannealed.Previousworkalso reported thatPol
II arrested by TOP1ccs is released from chromatin (Sordet et al.,
2008) and degraded by the proteasome (Desai et al., 2003), which
would enable strand separation. DNA strand separation may be
further facilitated by the removal of single-stranded DNA (ssDNA)
fragmentsofR-loops thatwe reporthere.Lastly, although theDNA
strands between TOP1ccs and stalled Pol II may be annealed,
their length has been estimated in vitro to be 10 bp (Bendixen
et al., 1990), and melting of the DNA duplex can readily occur
over such a short length (Ran et al., 2013).
Non-replicative DSBs likely occur spontaneously in cells
becauseTOP1ccscanbe trappedunderphysiological conditions,
including oxidative base damage, alkylation and nicks (Pommier
et al., 2014), and ribonucleotide misincorporation (Huang et al.,
2015, 2017; Kim et al., 2011; Sparks and Burgers, 2015). Consis-
tently,ourdata indicate thatDSBsdependenton theprocessingof
both TOP1ccs and R-loops are produced in non-replicating cells
under physiological conditions (Figures 7A and 7B). Geneticemoved from the chromatin. (d) The two DNA strands separate forming a DSB.
r R-loop levels (red). Genes mutated in these disorders are indicated. ALS,
ngiectasia; SCAN, spinocerebellar ataxia with axonal neuropathy; SMA, spinal
defects in the transcription-blocking TOP1cc repair pathway
(TDP1, PNKP, and XRCC1) and in the resolution of R-loops
(SETX) are associated with genomic instability and cause neuro-
logical diseases, primarily cerebellar ataxia and amyotrophic
lateral sclerosis (see Figure 7D; Dumitrache and McKinnon,
2017; Groh et al., 2017; Hoch et al., 2017; Takashima et al.,
2002). This study reveals that such genetic defects enhance tran-
scriptionalDSBs inCPT-treatedquiescentcellsdue toan increase
in their production and a defect in repair. This raises the possibility
that these persistent DSBs would accumulate over time, contrib-
uting to the neurodegenerative phenotype. Consistently, this
study (Figure 7C) and previous work (Cristini et al., 2016) showed
that such DSBs and their modulation by factors controlling their
production can kill non-replicating cells. A further connection be-
tween TOP1ccs, R-loops, and neurological disease has recently
been reported. Cells bearing the C9orf72 expansion repeat, the
most common genetic cause of amyotrophic lateral sclerosis,
accumulatebothTOP1ccsandR-loops, resulting inDSBs (Walker
et al., 2017). In addition, deficiency of ATM or DNA-PK, which el-
evates TOP1cc levels (Cristini et al., 2016; Katyal et al., 2014), can
also cause neurological diseases (Kannan et al., 2018; Savitsky
et al., 1995). Neurons may be prone to produce transcriptional
DSBs as a result of high rates of oxygen consumption, which pro-
duces reactive oxygen species that canstabilize TOP1ccs (Daroui
et al., 2004; Pommier, 2006; Pommier et al., 2014). We also note
that oxidative stress has been implicated in several neurodegen-
erative diseases (Barnham et al., 2004). Furthermore, DSBs may
be particularly deleterious in neurons due to their reduced DNA
repair capability as compared to proliferating cells (Rass et al.,
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Lab-Tek RS chamber slides ThermoFisher Scientific Cat# 154526KLEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Olivier
Sordet (olivier.sordet@inserm.fr). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cells and Treatments
Primary human lung embryonic WI38 fibroblasts (from a 3-month-gestation aborted female fetus) immortalized with hTERT were ob-
tained fromCarl Mann (CEA, Gif-sur-Yvette, France) (Jeanblanc et al., 2012). Cells were cultured at 37C inmodified Eagle’s medium
(MEM) supplemented with 10% (v/v) fetal bovine serum, 1 mM sodium pyruvate, 2 mM glutamine and 0.1 mM non-essential amino
acids. To induce quiescence, cells were washed twice with serum-free medium and cultured for 72 h in medium supplemented as
described above but with 0.2% (v/v) serum. To control the induction of quiescence in Figures S1A and S1B, cells were incubated
with 10 mM EdU for 30 min and the incorporated EdU into DNA was detected using the Click-iT EdU Alexa Fluor 647 imaging kit
(ThermoFisher Scientific) according to the manufacturer’s protocol. SV40-transformed human fibroblasts XP2Y0 (XPF-deficient,
GM08437, from a 64-year-old female), XP2Y0 + XPF WT, and XP2Y0 + XPF-D676A were gifts from Orlando Scha¨rer (Stony Brook
University, NY, USA) (Staresincic et al., 2009) and cultured at 37C in Dulbecco’s Modified Eagle’s Medium (DMEM) high glucose
supplemented with 1 mM sodium pyruvate and 10% (v/v) fetal bovine serum. Human colon carcinoma HCT116 cells (from an adult
male) parental and TDP1 KO (Al Abo et al., 2017) and human osteosarcoma U2OS cells (from a 15-year-old female) inducible for
mCherry or mCherry-RNH1 (Britton et al., 2014) were cultured at 37C in DMEM supplemented with 10% (v/v) fetal bovine serum.
To express mCherry or mCherry-RNase H1, U2OS cells were treated with 2 mg/ml doxycycline for 24 h. Drugs and chemicals
used for treatments are CPT, FLV, MG132, myricetin and doxycycline from Sigma-Aldrich, and bortezomib from Selleckchem. All
these agents were dissolved in DMSO except for doxycycline, which was in water. In all the experiments, mock samples were treated
with the vehicle only.e3 Cell Reports 28, 3167–3181.e1–e6, September 17, 2019
METHOD DETAILS
Immunofluorescence Microscopy
Cells were seeded in poly-L-lysine (Sigma-Aldrich)-coated 96-well plates (CellCarrier; PerkinElmer). After treatment, cells were
washed twice with PBS and fixed with 3.7% paraformaldehyde for 15 min. After two washes with PBS, cells were permeabilized
with 0.5% Triton X-100 for 15 min and washed twice with PBS. Cells were incubated with 8% bovine serum albumin (BSA) in
PBS for 1 h before incubation with a mouse anti-gH2AX antibody (05-636; Millipore) and/or a rabbit anti-p53BP1 antibody (#2675;
Cell Signaling Technology) diluted at 1/500 in 1% BSA in PBS for 2 h. Cells were washes three times with PBS and incubated
with the appropriate secondary antibody coupled to Alexa Fluor 488, 594 or 647 (ThermoFisher Scientific) diluted at 1/500 in 1%
BSA in PBS for 1 h. After three washes with PBS, nuclei were stained with 1 mg/ml Hoechst 33342 for 15 min, washed twice with
PBS and stored at 4C until analysis. To identify G1 nuclei, cells were incubated with 10 mM EdU for 30 min before treatment with
CPT. The incorporated EdU into DNA was detected using the Click-iT EdU Alexa Fluor 647 Imaging Kit (ThermoFisher Scientific) ac-
cording to the manufacturer’s protocol. After the Click-iT reaction, cells were processed for immunolabelling as described above
starting at the 8% BSA step.
96-well plates were scanned with a 20X objective using an Operetta High-Content Imaging System or an Operetta CLS High-Con-
tent Imaging System (PerkinElmer) with Harmony software (version 4.1 or 4.8). After data acquisition, subsequent analyses were per-
formed with Columbus software (version 2.5.0 or 2.8.2). gH2AX and p53BP1 foci were detected with the ‘‘C’’ method. Variations of
the number of foci between independent experiments can be related to experimental variabilities, which include the automatic count-
ing of foci with Columbus software that depends on the ratio between the signal intensity of foci and background noise. To compare
independent experiments, the number of gH2AX/p53BP1 foci were normalized in each individual experiment as indicated in the
figure legends. For graphical representation of foci distribution, we used box-and-whisker plots with GraphPad Prism 6 software
with the following settings: boxes: 25-75 percentile range; whiskers: 10-90 percentile range; horizontal bars: median number of
foci; ‘‘+’’: mean number of foci.
In Figures 1A and 5A, cells were seeded in poly-L-lysine-coated Lab-TekTM RS chamber slides (NalgeNunc), labeled as described
above and slides were mounted using Mowiol 4-88 (Millipore) containing 4’,6-diamidino-2-phenylindole (DAPI). Slides were visual-
ized with an inverted confocal microscope (LSM 780; ZEISS) with the objective Plan-Apochromat 63x / 1.4 Oil DIC III. In Figure 5A,
gH2AX foci were counted with ImageJ (version 1.48v) as described previously (Cristini et al., 2016).
Chromatin Immunoprecipitation (ChIP)
Chromatin immunoprecipitation was performed as described previously (Cristini et al., 2018; Groh et al., 2014). Briefly, cells were
crosslinked with 1% formaldehyde at 37C for 15 min and the reaction was stopped by adding 0.125 M glycine for 5 min. Pelleted
cells were first subjected to lysis with cell lysis buffer (5mMPIPES pH 8.0, 85mMKCl, 0.5%NP-40 supplemented with 0.5mMPMSF
and 1X Complete EDTA-free protease inhibitors, Sigma-Aldrich) to isolate nuclei. Pelleted nuclei were then incubated in nuclear lysis
buffer (50 mM Tris-HCl pH 8.0, 5 mM EDTA, 1% SDS supplemented with 0.5 mM PMSF and 1X Complete EDTA-free protease in-
hibitors, Sigma-Aldrich) and sonicated (Diagenode Bioruptor). After removal of insoluble material by centrifugation, samples were
diluted with ChIP IP buffer (16.7 mM Tris-HCl pH 8.0, 1.2 mM EDTA pH 8.0, 167 mM NaCl, 0.01% SDS, 1.1% Triton X-100 supple-
mented with 0.5 mM PMSF and 1X Complete EDTA-free protease inhibitors, Sigma-Aldrich) and precleared by adding protein A
agarose beads (16-157; Millipore). Chromatin was then incubated overnight at 4C with anti-gH2AX (07-164; Millipore), anti-H2AX
(07-627; Millipore), anti-SETX (NB100-57542; Novus Biologicals), anti-XPF (ab76948; Abcam Lot#GR172751) antibodies or no anti-
body. Immunocomplexes were retrieved by incubation with protein A agarose beads (16-157; Millipore). Beads were then washed
once with buffer A (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 0.1% SDS, 1% Triton X-100 and 0.15 M NaCl), once with buffer B
(20 mM Tris-HCl pH 8.0, 2 mM EDTA, 0.1% SDS, 1% Triton X-100 and 0.5 M NaCl), once with buffer C (10 mM Tris-HCl pH 8.0,
1 mM EDTA, 1% NP-40, 1% Sodium Deoxycholate and 0.25 M LiCl) and then twice with buffer D (10 mM Tris-HCl pH 8.0 and
1 mM EDTA). Beads were eluted in 1% SDS and 0.1 M NaHCO3 and samples decross-linked by addition of RNase A and NaCl
(0.3 M) at 65C for at least 4 h. After 2 h proteinase K (Sigma-Aldrich) digestion at 45C, DNA was purified with QIAquick PCR puri-
fication kit (QIAGEN), and analyzed by qPCRwith Rotor-GeneQ (QIAGEN). The amount of immunoprecipitated material at a partic-
ular gene region was calculated as the percentage of input after subtracting the background signal (no antibody control). Unless
otherwise stated, data were normalized to the DMSO-treated sample in each experiment, which was set equal to 1. The primers
used for ChIP are listed in Table S1.
RNA/DNA Immunoprecipitation (DRIP)
RNA/DNA immunoprecipitation was carried out as described in (Cristini et al., 2018; Skourti-Stathaki et al., 2011) with the S9.6 anti-
body (Boguslawski et al., 1986). Briefly, isolated non-crosslinked nuclei were subjected to nuclear lysis (50mMTris-HCl pH 8.0, 5mM
EDTA, 1% SDS) and digestion with Proteinase K (Sigma-Aldrich) for 3 h at 55C. Genomic DNA was precipitated, resuspended in IP
dilution buffer (16.7 mM Tris-HCl pH 8.0, 1.2 mM EDTA, 167 mM NaCl, 0.01% SDS, 1.1% Triton X-100) and sonicated (Diagenode
Bioruptor) to obtain DNA fragments of about 500 bp. Sonicated genomic DNAwas then precleared with protein A agarose beads (16-
157; Millipore) in presence of protease inhibitors (0.5 mM PMSF, 0.8 mg/ml pepstatin A, 1 mg/ml leupeptin). 10 mg of genomic DNA
were incubated overnight at 4C with 15 ml of S9.6 antibody or no antibody control. Addition of beads, washes, and elution stepsCell Reports 28, 3167–3181.e1–e6, September 17, 2019 e4
were carried out following the same procedure described for ChIP. RNase H sensitivity was performed by adding 1.7 U RNase H
(M0297; NEB) per microgram of genomic DNA for 2.5 h at 37C before IP step. The amount of immunoprecipitated material at a
particular gene region was calculated as the percentage of input after subtracting the background signal (no antibody control). Unless
otherwise stated, data were normalized to the b-actin TSS proximal probe of the DMSO-treated sample in each experiment, which
was set equal to 1. The primers used for DRIP are listed in Table S1.
RNA/DNA Hybrid Slot Blot
Slot blot experiments were carried out as described (Cristini et al., 2018) using the S9.6 antibody (Boguslawski et al., 1986). Genomic
DNA preparation and RNase H digestion were performed following the procedure described for DRIP. For loading control, 350 ng of
genomic DNA were heated at 95C for 10 min, loaded on the slot blot and the membrane was denatured for 10 min in 0.5 M NaOH,
1.5 M NaCl, and neutralized for 2 min in 0.5 M Tris-HCl pH 7.2, 1.5 M NaCl. The membrane was probed with an anti-ssDNA antibody
(MAB3034; Millipore) after UV crosslinking and saturating. Images were acquired with LAS-4000 (Fujifilm). S9.6 and ssDNA signals
were quantified using Image Studio Lite software (Li-COR Biosciences).
RNA/DNA Hybrid Co-immunoprecipitation
RNA/DNA hybrid co-IP was performed as described (Cristini et al., 2018) using the S9.6 antibody (Boguslawski et al., 1986). Briefly,
non-crosslinked nuclei were incubated in RSB buffer (10 mM Tris-HCl pH 7.5, 200 mM NaCl, 2.5 mMMgCl2) with 0.2% sodium de-
oxycholate, 0.1% SDS, 0.05% sodium lauroyl sarcosinate and 0.5% Triton X-100, and sonicated for 10 min (Diagenode Bioruptor).
Samples were then diluted 4 times in RSB with 0.5% Triton X-100 (RSB + T) before IP with the S9.6 antibody, bound to protein
A dynabeads (Invitrogen), and preblocked with 0.5%BSA/PBS for 2 h. IP was performed in presence of 0.1 ng of RNase A (PureLink,
Invitrogen) per microgram of genomic DNA. Beads were then washed 4 times with RSB + T and 2 times with RSB. IPs were eluted in
1x LDS (Invitrogen), 100 mM DTT for 10 min at 70C for SDS-PAGE, and in 1% SDS and 0.1 M NaHCO3 for 30 min at room temper-
ature for RNA/DNA hybrid slot blot. Where indicated, RNA/DNA hybrid competitors were added during the IP step at 1.3 mM
concentration (Phillips et al., 2013). RNA/DNA hybrids were prepared as described in (Cristini et al., 2018; Phillips et al., 2013)
(ssDNA- CGGTGTGAATCAGAC; ssRNA-GUCUGAUUCACACCG). RNA/DNA hybrid IP with RNase H treatment was carried out
as described previously (Cristini et al., 2018). Proteins were separated on 4%–12% Bis-Tris or 3%–8% Tris-Acetate gels by SDS-
PAGE (Invitrogen) and immunoblotted with anti-XPF (ab76948; Abcam Lot#GR172751) and anti-lamin B1 (ab16048; Abcam) anti-
bodies. XPF signal was quantified by using ImageJ (version 1.52h). XPF IP signal was normalized to XPF input signal and the
DMSO-treated sample was set to 1.
Cell Extracts and Immunoblotting
Cell extracts were obtained by lysing cells for 15 min at 4C in buffer containing 50mM Tris-HCl (pH 8.0), 300mMNaCl, 0.4%NP-40,
10mMMgCl2 and 5mMDTT, supplemented with protease and phosphatase inhibitors (Halt Protease & Phosphatase Inhibitor Cock-
tail; ThermoFisher Scientific). After centrifugation (10,000 x g, 20 min), supernatants were diluted (v/v) in 50 mM Tris-HCl (pH 8.0),
0.4% NP-40 and 5 mM DTT. Proteins were separated by SDS-PAGE and immunoblotted with the following antibodies at dilutions
recommended by the manufacturer: anti-pan-actin (MAB1501; Millipore), anti-ARTEMIS (#13381; Cell Signaling Technology), anti-
mCherry (GTX128509; GeneTex), anti-CtIP (A300-488A; Bethyl), anti-FEN1 (A300-255A; Bethyl), anti-KAP1 (A300-274A; Bethyl),
anti-DNA ligase3 (A301-636A; Bethyl), anti-MRE11 (A303-998A; Bethyl), anti-MUS81 (ab14387; Abcam), anti-PNKP (A300-257A;
Bethyl), anti-SETX (A301-104A; Bethyl), anti-TDP1 (H00055775-A01; Abnova Corporation), anti-atubulin (T5168; Sigma-Aldrich),
anti-XPF (A301-315A; Bethyl), anti-XPG (A301-484A; Bethyl), and anti-XRCC1 (A300-065A; Bethyl). Immunoblotting was revealed
by chemiluminescence using a ChemiDoc MP Imaging System (Bio-Rad).
Comet Assays
Neutral and alkaline comet assays were performed according to the manufacturer’s instructions (Trevigen), except that electropho-
resis was performed at 4C. Slides were scanned by using a AxioObserver Z1 fluorescencemicroscope (ZEISS) with the objective EC
Plan-Neofluar 10X / 0.3 Ph1. Comet tail moments were measured with ImageJ software (version 1.51n) with the plugin OpenComet
(http://www.cometbio.org).
siRNA Transfection
Cells were transfected with siRNA duplexes using Dharmafect 4 transfection reagent (Dharmacon) for 24 h before inducing quies-
cence for 72 h. siRNAs used are pools of 4 siRNAs per gene from Dharmacon [CtIP: M-011376-00-0005; ARTEMIS (DCLRE1C):
M-004269-02; DNA ligase 3: M-009227-02; FEN1: M-010344-01; MRE11: M-009271-01; MUS81: L-016143-01; PNKP:
M-006783-02; RAD52: M-011760-01; TDP1: M-016112-01; XPF: M-019946-00; XPG: M-006626-01; XRCC1: M-009394-01],
or are individual siRNAs from Eurofins Genomics (SETX: 50-UUGGAGUAGUUGAUACCCGAAdTdT-30), Dharmacon (AQR:
D-022214-03; LUC control sequence: D-001400-01), or Eurogentec (nontargeting control sequence: SR-CL000-005).e5 Cell Reports 28, 3167–3181.e1–e6, September 17, 2019
Quantification of Global RNA Transcription
Global RNA transcription was detected in cells using the Click-iT RNA Alexa Fluor 488 Imaging Kit (ThermoFisher Scientific). Cells
were seeded in poly-L-lysine-coated Lab-TekTM RS chamber slides (NalgeNunc) and incubated with 1 mM EU for 30 min to label
newly synthesized RNA, which was detected according to the manufacturer’s instructions. Slides were mounted using Mowiol
4-88 (Millipore) containing PI and scanned by using an AxioObserver Z1 fluorescence microscope (ZEISS) with the objective
Plan-Apochromat 20X / 0.8. Pictures were analyzed with ImageJ (version 1.48v).
Cell Viability Assays
CellTiter-Blue cell viability assayswere performed into 96-well microplates (CellCarrier; PerkinElmer) according to themanufacturer’s
instructions (Promega) and fluorescencewasmeasured at 545-20 nmEx/600-40 nmEmusing aCLARIOstarmicroplate reader (BMG
Labtech). Viability of untreated cells was set to 100%.
QUANTIFICATION AND STATISTICAL ANALYSIS
Information on biological replicates (n) is indicated in the figure legends. For immunofluorescence microscopy experiments, at least
500 nuclei were analyzed when using the Operetta/Columbus system and at least 150 nuclei when using counting with ImageJ in
Figure 5A. For comet assays, at least 150 nuclei were analyzed. Experimental differences were tested for significance with one-
way ANOVA or two-tailed unpaired t test by using GraphPad Prism 6 software. Ns indicates not significant differences. p < 0.05
is considered significant. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
DATA AND CODE AVAILABILITY
This study did not generate/analyze datasets/code.Cell Reports 28, 3167–3181.e1–e6, September 17, 2019 e6
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 Name Forward sequence Reverse sequence 
βActin TSS CGGGGTCTTTGTCTGAGC CAGTTAGCGCCCAAAGGAC 
βActin Gene body#1  GGAGCTGTCACATCCAGGGTC TGCTGATCCACATCTGCTGG 
βActin Gene body#2 TTACCCAGAGTGCAGGTGTG CCCCAATAAGCAGGAACAGA 
γActin TSS CCGCAGTGCAGACTTCCGAG CGGGCGCGTCTGTAACACGG 
γActin Gene body GTGACACAGCATCACTAAGG ACAGCACCGTGTTGGCGT 
PTB Gene body GCCGTTGGTACAAAGGTAGG GCCCCTTAGGAATGGAAAAG 
Gemin7 Gene body TCTTCTTCCACCTGGACCAC GGGACAGAGAGAGTGCCTTG 
IL4 Gene body TTCAGGTGACAAGTGCCACAG CTGGTTGGCTTCCTTCACAG 
Intergenic  ACCCAGCACCCCCTAATACC AGCCGGACATGCTTCCAGAG 
	
Table S1: Primer sequences, Related to STAR Methods. 
Intergenic: genomic region located 6 kb upstream to the TSS of β-Actin.  
	
